Corsair Pharma

Silver Spring
United States

Show jobs for this employer

About Corsair Pharma

Corsair Pharma, Inc. is a development stage biotechnology company operating as a portfolio company of Velocity Pharmaceutical Development, LLC and is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.


CEO: David Collier

3 articles with Corsair Pharma